Zinc Supplementation for Infants and Children with HIV Infection

Zhang, Lingli; Zeng, Linan; Gui, Ge; Duan, Yanjun; Hu, Zhiqiang

doi:10.1016/b978-0-12-800767-9.00010-8

Cited by 1 publication

(1 citation statement)

References 56 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A proper ratio balance may be needed for better reproductive outcomes [ 42 ]. Another reported consequence of an imbalance in the ratio is related to an immune dysregulation association with an HIV infection [ 43 ]. Th1/Th2 ratio imbalance caused natural killer (NK) cell activity, differentiation, and cytotoxic CD8 + T cell activation to decrease significantly.…”

Section: Discussionmentioning

confidence: 99%

Intranasal Immunization for Zika in a Pre-Clinical Model

Shah,

Patel,

Bagwe

et al. 2024

Viruses

View full text Add to dashboard Cite

Humans continue to be at risk from the Zika virus. Although there have been significant research advancements regarding Zika, the absence of a vaccine or approved treatment poses further challenges for healthcare providers. In this study, we developed a microparticulate Zika vaccine using an inactivated whole Zika virus as the antigen that can be administered pain-free via intranasal (IN) immunization. These microparticles (MP) were formulated using a double emulsion method developed by our lab. We explored a prime dose and two-booster-dose vaccination strategy using MPL-A® and Alhydrogel® as adjuvants to further stimulate the immune response. MPL-A® induces a Th1-mediated immune response and Alhydrogel® (alum) induces a Th2-mediated immune response. There was a high recovery yield of MPs, less than 5 µm in size, and particle charge of −19.42 ± 0.66 mV. IN immunization of Zika MP vaccine and the adjuvanted Zika MP vaccine showed a robust humoral response as indicated by several antibodies (IgA, IgM, and IgG) and several IgG subtypes (IgG1, IgG2a, and IgG3). Vaccine MP elicited a balance Th1- and Th2-mediated immune response. Immune organs, such as the spleen and lymph nodes, exhibited a significant increase in CD4+ helper and CD8+ cytotoxic T-cell cellular response in both vaccine groups. Zika MP vaccine and adjuvanted Zika MP vaccine displayed a robust memory response (CD27 and CD45R) in the spleen and lymph nodes. Adjuvanted vaccine-induced higher Zika-specific intracellular cytokines than the unadjuvanted vaccine. Our results suggest that more than one dose or multiple doses may be necessary to achieve necessary immunological responses. Compared to unvaccinated mice, the Zika vaccine MP and adjuvanted MP vaccine when administered via intranasal route demonstrated robust humoral, cellular, and memory responses. In this pre-clinical study, we established a pain-free microparticulate Zika vaccine that produced a significant immune response when administered intranasally.

show abstract

Section: Discussionmentioning

confidence: 99%